Category: clinical study retractions

Paper on rare pediatric lung cancer retracted for misstatements, unknowing authors

logo-journalecancermedicalscience (officially in the running for the most cumbersome journal title we’ve run across) has retracted a 2013 case report for a litany of sins.

The article, “Primary extraosseous Ewing sarcoma of the lung in children,” came from a group in France: Nidal Alsit, Clara Fernandez, Jean Luc Michel , Linda Sakhri, Audrey Derouet and Augustin Pirvu.

Or at least that’s what the author information suggested. Continue reading Paper on rare pediatric lung cancer retracted for misstatements, unknowing authors

Paper by NASA scientists retracted for plagiarizing NASA report

레이아웃 1A team of researchers including NASA scientists have retracted a December 2012 article because it plagiarized…a 2000 NASA report.

Here’s the notice for “A Fosmid Cloning Strategy for Detecting the Widest Possible Spectrum of Microbes from the International Space Station Drinking Water System,” published in Genomics & Informatics: Continue reading Paper by NASA scientists retracted for plagiarizing NASA report

Retraction of 19-year-old Nature paper reveals hidden cameras, lab break-in, evidence tampering

nature bezouskaWe’ve often found that when some authors refuse to sign retraction notices, there’s a much bigger story than terse notices let on. And a retraction in this week’s Nature of a 19-year-old paper is a shining example of that.

Here’s the brief notice for “Oligosaccharide ligands for NKR-P1 protein activate NK cells and cytotoxicity,” a 1994 paper by researchers from the UK and the Czech Republic that had already been subject to a 1996 correction: Continue reading Retraction of 19-year-old Nature paper reveals hidden cameras, lab break-in, evidence tampering

Paper on vulvar tumor retracted. Why? Journal won’t say

JLGTCancer of the vulva may well be a topic most people do not want to discuss. But we wish the Journal of Lower Genital Tract Disease (the official journal of several societies, including the American Society for Colposcopy and Cervical Pathology, the Australian Society for Colposcopy and Cervical Pathology and the Society of Canadian Colposcopists) had been a bit more forthcoming about its retraction of a 2013 paper on the subject.

The article, “Granular Cell Tumor of the Vulva,” appeared in the January issue of the journal from a group whose last last author was Sofia Vázquez Navarrete, a pathologist at La Línea de la Concepción, in Cádiz, Spain.

Its abstract stated: Continue reading Paper on vulvar tumor retracted. Why? Journal won’t say

Former Duke researcher charged with embezzlement has a paper retracted

j app physA new retraction notice in the Journal of Applied Physiology gives only a hint at the problems in the paper, but what it does say has led us to a story about one of its co-authors.

Here’s the notice, from a team at Duke: Continue reading Former Duke researcher charged with embezzlement has a paper retracted

Cell line mixup causes retraction of paper on blood vessel damage

britjournnutWe’ve written before about retractions for cell lines that turn out not to be what researchers thought they were. In a few cases, that has involved contamination by HeLa cells, named for Henrietta Lacks. Today, we note the retraction of a paper whose authors, from Taiwan, thought they were using human muscle cells that line blood vessels when they were actually studying such cells from rat embryos.

Here’s the notice in the British Journal of Nutrition for “Molecular mechanism of green microalgae, Dunaliella salina, involved in attenuating balloon injury-induced neointimal formation”: Continue reading Cell line mixup causes retraction of paper on blood vessel damage

Authors of retracted sex paper won Ig Nobel for MRI study of coitus — and had another retraction

bmj mri
Midsagittal image of the anatomy of sexual intercourse, from BMJ http://bit.ly/v2ZkxQ

Yesterday we reported on the retraction for data misuse and plagiarism of a 21-year-old paper on sex and female cancer patients. Turns out we missed a couple of rather interesting details about the authors of the pulled article.

One tidbit, for example, is that one of them, Willibrord Weijmar Schultz,  is science royalty, having been a member of a team that won the 2000 Ig Nobel prize in medicine. Their heralded study, “Magnetic resonance imaging of male and female genitals during coitus and female sexual arousal,” published in 1999 in the BMJ: An inside-the-MRI look at the human body having sex. Continue reading Authors of retracted sex paper won Ig Nobel for MRI study of coitus — and had another retraction

Lacking “scientific and analytical rigor,” 8-year-old lymphoma paper falls to retraction

leuklympjuly13Leukemia & Lymphoma has retracted 2004 paper by a group of authors in Mexico after concluding that, well, the article never should have been accepted to begin with.

The article, “Adjuvant radiotherapy in stage IV diffuse large cell lymphoma improves outcome,” came from oncologists at the National Medical Center. Its abstract (still available on Medline) states: Continue reading Lacking “scientific and analytical rigor,” 8-year-old lymphoma paper falls to retraction

21-year-old article on the sex lives of women with cancer retracted for data misuse

journal of sex researchHere’s one for the way-back machine.

The Annual Review of Sex Research (which is a supplement to the Journal of Sex Research) has retracted a 1992 paper by a group of researchers who lifted much of their analysis from two even older articles by another scholar. At 21 years post-publication, this is one of the oldest — but not the record-oldest — retractions we’ve covered to date.

The pulled paper, “Sexuality and cancer in women,” came from Willibrord C. M. Weijmar Schultz, Harry B. M. Van de Wiel, Daniela E. E. Hahn, and Mels F. Van Driel. (Weijmar Schultz and Van de Wiel  are co-authors of this rather curious passage about the appropriateness of sexual contact between doctors and patients:

Continue reading 21-year-old article on the sex lives of women with cancer retracted for data misuse

Why I retracted my Nature paper: A guest post from David Vaux about correcting the scientific record

Last month, Ivan met David Vaux at the 3rd World Conference on Research Integrity in Montreal. David mentioned a retraction he published in Nature, and we thought it would be a great guest post on what it’s like to retract one of your own papers in an attempt to clean up the literature.

vaux
David Vaux

In September 1995 Nature asked me to review a manuscript by Bellgrau and co-workers, which subsequently appeared. I was very excited by this paper, as it showed that expression of CD95L on Sertoli cells in allogeneic mismatched testes tissue transplanted under the kidney capsule was able to induce apoptosis of invading cytotoxic T cells, thereby preventing rejection. As I wrote in a News and Views piece, the implications of these findings were enormous – grafts engineered to express CD95L would be able to prevent rejection without generalized immunosuppression.

In fact, I was so taken by these findings that we started generation of transgenic mice that expressed CD95L on their islet beta cells to see if it would allow islet cell grafts to avoid rejection and provide a cure for diabetes in mismatched recipients.

Little did we know that instead of providing an answer to transplant rejection, these experiments would teach us a great deal about editorial practices and the difficulty of correcting errors once they appear in the literature. Continue reading Why I retracted my Nature paper: A guest post from David Vaux about correcting the scientific record